| # | Drug | Count |
|---|---|---|
| 0 | TERIPARATIDE | 8 |
| 1 | DENOSUMAB | 6 |
| 2 | ALENDRONATE SODIUM | 4 |
| 3 | CALCIUM | 4 |
| 4 | DIAZEPAM | 3 |
| 5 | ERGOCALCIFEROL | 3 |
| 6 | LETROZOLE | 3 |
| 7 | MEDROXYPROGESTERONE ACETATE | 3 |
| 8 | OMEPRAZOLE | 3 |
| 9 | OMEPRAZOLE MAGNESIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 1 | 0.0007 |
| 1 | RESMETIROM | 1 | 0.0004 |
| 2 | PEGVISOMANT | 1 | 0.0002 |
| 3 | FOSTAMATINIB | 1 | 0.0001 |
| 4 | TOLTERODINE TARTRATE | 1 | 0.0001 |
| 5 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 6 | ERGOCALCIFEROL | 3 | 0.0001 |
| 7 | ASFOTASE ALFA | 1 | 0.0001 |
| 8 | AMLODIPINE BESYLATE AND VALSARTAN | 1 | 0.0001 |
| 9 | MAGNESIUM HYDROXIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Parathyroid Hormone Analog [EPC] | 8 |
| 1 | RANK Ligand Inhibitor [EPC] | 6 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 3 | Calcium [EPC] | 4 |
| 4 | Corticosteroid [EPC] | 4 |
| 5 | Aromatase Inhibitor [EPC] | 3 |
| 6 | Benzodiazepine [EPC] | 3 |
| 7 | Estrogen [EPC] | 3 |
| 8 | Proton Pump Inhibitor [EPC] | 3 |
| 9 | Provitamin D2 Compound [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 2 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | Parathyroid Hormone Analog [EPC] | 8 | 0.0001 |
| 5 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 7 | RANK Ligand Inhibitor [EPC] | 6 | 0.0000 |
| 8 | Calcium [EPC] | 4 | 0.0000 |
| 9 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |